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Experimental allergic encephalomyelitis (EAE) 1 is a  clear example of an au- 
toimmune disease mediated by class II-restricted T  lymphocytes (1-5).  Certain 
forms  of  EAE  are  characterized  by  relapsing  paralysis,  with  histopathology 
revealing  both  perivascular  lymphocytic cuffs and  demyelination.  Because  of 
these features, chronic relapsing  EAE is often cited as a  model for the human 
disease multiple sclerosis (MS)  (6).  Further similarities exist between  EAE and 
MS, including the presence of T  helper cells in the inflammatory lesions (7, 8), 
and the linkage of susceptibility for both EAE and MS to immune response genes 
(9,  10).  With  the capability for  cloning antigen-specific T  cells (1 1),  it is  now 
possible to analyze the precise cellular and immunogenetic mechanisms involved 
in EAE. 
Recently, it has been shown (12,  13) that the N-terminal  1-37 amino acid (aa) 
peptide of rat or guinea pig myelin basic protein (MBP) can induce EAE in PL/J 
(H-2 ") mice, while the C-terminal 89-169 aa peptide is encephalitogenic in SJL/ 
J  (H-2 s) mice. The (PL/J ×  SJL/J)F1 [(PLSJ)FI] mice do not respond to MBP in 
a  codominant manner.  Instead,  only the  N-terminal  peptide  of MBP  induces 
EAE in the (PLSJ)F1 mouse (12,  13). 
To characterize the T  cells involved in the encephalitogenic response, MBP- 
specific  T  cell  lines  and  clones  have  been  isolated  from  (PLSJ)Ft  mice  after 
immunization with rat or bovine  MBP.  The separate determinants recognized 
by these  clones have  been  investigated  using peptides  derived  from  MBP.  In 
addition,  the  pattern  of restriction  to  I-A  or  I-E  class  II  molecules has  been 
analyzed for each clone. With both the initial MBP-primed T  cell lines and the 
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clones isolated from these  lines,  we have observed a  paucity of proliferative T 
cells recognizing MBP in association with parental I-A  s class II molecules. 
The majority of the clones recognize an epitope within the N-terminus of rat 
MBP, although not all of these recognize a determinant shared with mouse (self) 
MBP.  By in vivo administration  of individual  clones, we have shown  that only 
those T  cell clones that recognize mouse (self) MBP are encephalitogenic. 
Following in vivo administration of these T  cells, various clinical forms of EAE 
have been observed, including acute-fulminant paralysis,  chronic relapsing pa- 
ralysis,  and  chronic unremitting paralysis.  Histopathologic examination of this 
paralytic disease induced with cloned T  cells at the light and electron microscopic 
levels has revealed features shared with MS, including perivascular lymphocytic 
infiltrates, primary demyelination, and remyelination within the central nervous 
system (CNS). 
Materials and Methods 
Mice.  PL/J,  B10.PL,  SJL/J, and (PL/J ×  SJL/J)F,  mice were purchased from The 
Jackson  Laboratory,  Bar  Harbor,  ME.  BALB/c,  B10,  B10.S,  C3H/HeJ,  (BALB/c  × 
SJL)F1, (B10 × SJL/J)Fj, and (C3H × SJL/J)FI mice were bred in our animal facilities in 
the Departments of Genetics and Medical Microbiology, Stanford University School of 
Medicine. Adult female mice, aged 12-20 wk, were used for all experiments. 
Culture Medium.  Complete culture media consisted of RPMI  1640 (Gibco Laborato- 
ries,  Grand Island,  NY)  supplemented with  10%  fetal calf serum (M.  A.  Bioproducts, 
Waikersville, MD), 5 ×  10  -5 M 2-mercaptoethanol, 2 mM glutamine, 100 ~g/ml penicillin, 
and 100 ~g/ml streptomycin. 
Preparation  of Antigens.  Rat, mouse, and guinea pig spinal cords were purchased from 
Pel-Freeze, Rogers, AR. Bovine spinal cord was purchased from Ferraro Meat Co. (San 
Jose, CA). Myelin basic protein was isolated from spinal cord tissue as previously described 
(14). Preparation and isolation of peptic peptides have been described previously (12). 
T Cell Lines and Clones.  Isolation and maintenance of proliferative T  cell lines and 
clones specific for MBP were carried out as described previously (5,  11).  T  cell clones 
PJR-25 and PJB-20 were derived from separate T  cell lines, which were generated from 
homozygote PL/J mice following immunization with rat and bovine MBP, respectively. 
Following immunization with rat MBP, a T  cell line and F~  clones were derived from 
(PLSJ)FI mice. 
Proliferation Assay.  To assay for proliferative response to MBP and MBP peptides, 104 
T cells were cultured with 5 X 105 irradiated APC from PL/J, SjL/j, or (PLSJ)F1 mice in 
0.2 ml of culture media in 96-well flat-bottomed microtiter plates. Each clone was tested 
with and without rat MBP. Cultures were pulsed using 1 #Ci/well of [3H]thymidine at 48 
h, and harvested 16 h later. The mean cpm of [3H]thymidine incorporation were calculated 
for triplicate cultures. SD calculated from replicate cultures were within 10% of the mean 
value. 
MonocIonal Antibodies (mAb).  All mAb have been described previously, mAb 10-2.16 
binds determinant lal7  on certain I-A chains,  including Aa  s and A/3  u (15).  mAb 40M 
binds Ia.1, a determinant on I-AB  u, but not I-A~ (16).  mAb  14-4-4  binds determinant 
Ia7, expressed on I-E chains (17,  31).  mAb Y-17  binds determinant Iam.44 on certain 
hybrid I-E molecules, including EaUE~ (18). In these blocking studies, 1/~g of each mAb 
was added at the beginning of culture to those wells containing cloned T  cells, antigen- 
presenting cells (APC), and rat MBP. mAb 10-2.16,  14-4-4, and Y-17 were provided by 
P. P. Jones (Stanford University, Stanford, CA). 
In Vivo Administration of MBP-specific T  Cell Clones.  14 d  after previous stimulation 
with rat MBP and irradiated APC, viable T cells were separated by centrifugation through 
a Ficoll gradient. These cells were then stimulated for 24 h in complete media containing 
10% supernatant from concanavalin A-stimulated rat spleen cells. ZAMVIL ET  AL.  2109 
Recipient mice were given low-dose whole body irradiation (350 rad) before intrave- 
neous injection of the T  cell clones. We (5) and others (20, 21) have shown that low-dose 
x-irradiation facilitates induction of EAE when given before injection of 106 cloned T 
cells.  Inactivated BordeteUa pertussis,  which is necessary for inducing EAE with MBP or 
MBP peptides (12), is not necessary in this model of T  cell clone-mediated paralysis (5). 
Histopathologic Techniques.  Mice were first anesthetized with carbon dioxide, and then 
perfused by intracardiac injection of 3.5% glutaraldehyde in phosphate-buffered saline. 
The brain and spinal cord were dissected free and segments from multiple levels along 
the neuraxis were embedded in paraffin or Epon. Paraffin-embedded tissues  were sec- 
tioned and stained with hematoxylin and eosin alone, or in combined with Luxol Fast 
Blue. Epon-embedded 1-t~m sections were stained with toluidine blue. Thin sections were 
stained with alcoholic uranyl acetate, and reviewed in a Hitachi II-uc transmission electron 
microscope at 70 kV. 
Results 
Bias  Against  Rat  MBP-specific  Responses  in  Association  With  H-2  ~ in  (PLSJ)F1 
T  Cell Clones.  A proliferative T  cell line specific for MBP was established after 
immunization of (PLSJ)F1 mice with rat MBP.  17 clones were then derived from 
this line. These clones were analyzed for their ability to recognize rat MBP in 
association with either parental  or (PLSJ)F1  APC.  In Table I, the proliferative 
responses of these clones to rat MBP are shown using APC from parental PL/J 
(H-2°), SJL/J (H-2S), or (PLSJ)F1 mice. 5 of the  17 clones proliferate in response 
to  rat  MBP  when  cultured  with  PL/J  and  (PLSJ)F~  APC.  This  indicates  that 
these five clones are  H-2  u restricted.  Only  1 of the  17  clones responds to rat 
MBP in association with SJL/J, B10.S (data not shown), and (PLSJ)F1 APC. This 
clone is  restricted to H-2  s.  11  clones respond  to rat MBP only when provided 
with  (PLSJ)FI  APC.  These  clones  must  rcognize rat  MBP  in  association  with 
hybrid (PLSJ)F~ determinants. Thus, recognition of rat MBP occurs in association 
with  H-2  ~ or H-2  ~u × s) F~  determinants  with a  paucity of H-T-restricted T  cell 
clones. 
To  confirm  that  this  bias  was  not  an  artifact  that  arose  from  cloning,  but 
instead reflected the characteristics of the population of T  cells primed to MBP, 
the MBP-specific (PLSJ)F1 T  cell line from which these clones were derived was 
also  analyzed.  Fig.  1  shows  that  the  (PLSJ)F1  T  cell  line  gives  a  significantly 
stronger response to rat MBP when cultured with PL/J or (PLSJ)F1 APC than 
when cultured with SjL/j APC.  This does not appear to be due to an intrinsic 
defect in either H-T-restricted T  cells or SjL/j APC. It is possible to expand the 
population  of H-T-restricted  T  cells  by  repeated  stimulation  on  SJL/J  APC. 
These results confirm other observations (22) that there is a  lack of priming to 
MBP in association with H-T in (PLSJ)F~ mice. 
Response  to Mouse (self) MBP Occurs Primarily  with  T  Cell  Clones Restricted  to 
H-2 u.  The results in Table II show that all five H-2U-restricted clones (pattern 
I) respond to mouse (self) MBP as well as to rat MBP. The one H-T restricted 
clone  (pattern  II)  does  not  respond  to  mouse  MBP.  Of the  11  H-2  tu × S)F~- 
restricted T  cell clones (patterns III and IV), only 1 clone (pattern I'V) proliferates 
in response to mouse MBP. 
The  inability  of H-T-restricted  T  cells  to  respond  to  mouse  MBP  can  be 
demonstrated in the (PLSJ)F~ T  cell line from which the 17 clones were derived. 
In  Fig.  2,  it  can  be  seen  that  (PLSJ)FI  T  cells respond  to  mouse  MBP  when 2110  T  CELL  CLONES  MEDIATE AUTOIMMUNE  PARALYSIS 
TABLE  I 
Determination of Parental or F1 H-2 Restriction Pattern  for 
MBP-specific T Cell Clones 
[SH]Thymidine incorporation (Acpm) by 
Clone  APC in response to MBP  Restriction 
PL/J  SJL/J  (PLSJ)F, 
Fi-5  62,133  130  47,121  PL/J 
FI-11  4,239  361  4,150  PL/J 
FI-12  182,910"  761  186,173  PL/J 
F1-21  24,086  62  28,589  PL/J 
F~-24  34,922  241  69,405  PL/J 
F~-13  312  91,324  49,272  SJL/J 
Fi-2  24  79  125,114  Fl 
Fi-8  5  94  96,041  Fl 
Fz-14  262  214  62,909  FI 
Fl-  15  112  294  237,455  F1 
F1-16  206  64  35,047  FI 
Fl-17  31  17  9,276  Fz 
FI-18  17  36  14,047  Fl 
Fi-20  23  83  11,589  Fl 
Fi-22  34  85  23,503  Fl 
Fi-27  200  130  107,987  Fl 
FI-28  43  307  153,113  F1 
PJR-25  88,065  -53  76,627  PL/J 
PJB-20  76,489  -4  69,154  PL/J 
All T cell clones are derived from (PLSJ)Fj mice, except PJR-25 and PJB- 
20, which were derived from homozygous PL/J mice. 10"cloned T cells 
were cultured with 5 ×  l0  s PL/J,  SJL/J,  or (PLSJ)F1 irradiated (3,000 
tad) splenic APC. Rat MBP was added at the beginning  of culture to ~ive 
a  6.7 ttM  final  concentration. Cultures were  labeled  with  1 /tCi [ H]- 
thymidine at 48 h, and harvested  16 h later.  Mean [3H]thymidine incor- 
poration was determined for triplicate  cultures.  For cultures  incubated 
with rat  MBP, the SD from replicate  cultures were  within  10%  of the 
mean value.  For background cultures incubated without  rat MBP, SD 
were within 15% of the mean. In all cases, background proliferation was 
<800 cpm. Uptake (Acpm) was determined by subtracting the mean cpm 
of background cultures from the mean cpm of cultures incubated with 6.7 
ttM  rat MBP. ND,  not determined. Positive proliferative  responses are 
underscored. 
cultured with PL/J  or (PLSJ)FI  APC, but do not respond to mouse MBP when 
cultured with SjL/j APC. (PLSJ)FI T  cells do respond to rat MBP in association 
with SJL/J APC, when tested at the same time. 
Specificity of Response of (PLSJ)F1 Clones to Peptide Fragments of  MBP.  In Table 
III,  the  proliferative  response  to  individual  MBP  peptides  is  shown  for  the 
(PLSJ)F1  MBP-specific T  cell clones. Rat and guinea pig MBP have identical aa 
sequences for residues  1-37, and differ from mouse MBP only at two residues 
(Fig. 3).  In mouse MBP, there is a  deletion of the His10 and Gly~l residues (23). 
Bovine  1-37  aa  sequence of MBP  also  has  this  deletion, but differs  from  rat, 
guinea pig, and mouse MBP at residues 2 and 17 (Fig. 3). 
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FIGURE  1.  Proliferative response of a (PLSJ)F1 MBP-specific  T  cell line to rat MBP with 
PL/J (open circles), SjL/j (open-triangles), and (PLSJ)FI (closed circles) APC. 104 (PLSJ)FI 
cells were cultured with 5 X 105 APC. Rat MBP was added at the beginning of culture. T cell 
clone SJ1.3, an MBP-specific  T cell clone derived from SJL/J mice, was tested on SJL/J APC 
as a positive control for SjL/j APC. The proliferative response for 104 SJ1.3 cells cultured 
with  5 x  105 SJL/J  APC and  100  gg/ml  rat  MBP gave 109,316  A cpm [3H]thymidine 
incorporation (data not shown). Proliferative responses were determined as described in Table 
1. 
MBP and respond to the N-terminal peptide of guinea pig or bovine MBP. The 
single clone, restricted to H-2  ~ (pattern II), responds to a unique determinant of 
rat MBP (Tables II and  IlI). All eight H-2  (" x S)F].restricte  d  T  cell clones tested 
(pattern III) respond to the N-terminal  1-37 aa peptide of guinea pig MBP, but 
do not proliferate in  response to intact mouse or bovine  MBP.  This indicates 
that these clones may recognize a  determinant of MBP requiring residues His10 
and Gly,], which are the only differences between rat or guinea pig MBP, and 
mouse MBP within the N-terminal  1-37 aa region. The pattern IV clone, which 
is hybrid H-2  (" × ~FI,  recognizes a  determinant that is common to all forms of 
MBP tested (Table II and  III).  Clones in pattern  II and  IV do not respond to 
any N-terminal MBP peptides tested, or to bovine MBP peptide 89-169,  which 
shares complete homology with large rat MBP for this region (23).  In contrast, 
certain  MBP-specific T  cell clones derived from SjL/j mice (19) do proliferate 
in response to peptide 89-169 when tested at the same time (data not shown). 
Ia Restriction Pattern of(PLSJ)FI  Clones.  Using mAb directed to specific I-A 
and  I-E gene products, we have determined the class II molecule used by each 
clone for recognition of MBP (24,  25).  Clones in pattern  I  are  inhibited from 
proliferating by mAb binding to  I-A", (Table 1V).  The single pattern  II  clone 
that responds to rat MBP on  SJL/J  or F]  APC  is not blocked by either of the 
anti I-A mAb.  Clones in pattern  III can be blocked by an mAb that recognizes 
1-Aft" but not  I-A/3  ~ chains.  The only hybrid H-2  (" × S)F~-restricted T  cell clone 
that  recognizes  mouse  MBP  (pattern  IV),  can  be  completely  inhibited  from 
proliferating  to  MBP  by  a  mAb  that  binds  a  determinant  on  I-E~  chains.  A 
summary  of the  class  II  restriction  and  MBP  recognition pattern  is  shown  in 
Table V. 
1-A s Can Be Expressed on (PLSJ)F1 APC.  We studied whether the bias against 
l-A~-restricted responses in the (PLSJ)Ft T  cell line and the (PLSJ)FI T  cell clones 2112  T  CELL CLONES  MEDIATE AUTOIMMUNE PARALYSIS 
TABLE  II 
Response of MPB-specific T Cell Clones to Rat, Bovine, or Mouse (self) MBP 
Pattern  Restriction  Clone 
[SH]Thymidine incorporation in response to MBP 
No  Rat MBP  Bovine MBP  Mouse MBP  antigen 
I  H-2 ~  FI-5  146 
1  H-2"  FI-11  315 
I  H-2 u  Fl-12  251 
I  H-2 u  F1-21  149 
1  H-2"  Fi-24  163 
70,215  16,747  50,737 
20,402  4,905  4,172 
182,424  42,147  209,622 
34,861  6,703  5,691 
53,044  39,048  41,904 
49,929  267  708 
125,266  171  146 
96,170  120  118 
63,008  233  144 
157,700  245  392 
35,173  138  206 
9,391  122  147 
14,125  75  109 
11,717  250  115 
23,733  211  177 
108,084  86  97 
II  H-2  ~  Fl-13  152 
III  H-2(u ×S)Fl  Fi-2  158 
IIl  H-2  (u ×  S)Fi  F1-8  129 
III  H-2(" ×  ~)Fl  Fl-14  99 
II1  H-2(~ ×  S)Fz  FF15  271 
Ill  H-2(~ ×  ~)Fl  Fl-16  126 
II1  H-2~u ×  ~)Fl  Frl7  115 
III  H-2(~ ×  S)Fi  FrI8  78 
lll  H_2(, x S)Fl  F~-20  128 
III  H-2(" ×°FI  FI-22  126 
III  H-2(" ×  ~)Fl  FF27  97 
IV  H-2(u ×S)Fz  F~-28  196  244,854  183,371  160,736 
I  H-2  u  PJR-25  484  95,736  4,602  76,006 
I  H-2  u  PJB-20  379  111,485  128,510  117,411 
Rat, bovine, or mouse MBP were added to cultures at a final concentration of 100 t~g/ml. 5 ×  105 
(PLSJ)FI APC were cultured with all (PLSJ~FI T  cell clones and 5 ×  105 PL/J APC were cultured 
I  I  with clones PJR-25 and clones PJB-20. The [ H]thym'dine 'ncorporation was determined as described 
in Table I. Positive proliferative  responses are underscored. 
was  due  to a  deficiency  in  expression  of I-A  s molecules  in  (PLSJ)F~  APC.  We 
tested  the  ability  of (PLSJ)FI  APC  to present  rat,  bovine,  and  mouse  MBP  to 
four T  cell  clones derived  from SJL/J mice immunized  with  bovine  MBP  (19). 
All four clones respond  to rat,  bovine, or mouse  MBP on APC of the following 
genotypes: SJL/J,  (B10  ×  SJL/J)F~,  (BALB/c ×  SJL/J)F~,  (C3H  ×  SJL/J)F~, and 
(PLSJ)F~.  The results  for a  representative  clone are shown in Fig. 4. 
Induction  of Autoimmune  Relapsing  Paralysis  with MBP-specific  T  Cell  Clones. 
Three  MBP-specific  T  celt  clones isolated  from three  independent  T  cell  lines 
have induced autoimmune  paralysis in  100%  (>100) (PLSJ)F~  mice tested.  Two 
of these T  cell clones,  PJR-25 and FI-12, were derived  from PL/J and (PLSJ)F~ 
mice,  respectively,  following immunization  with  rat  MBP.  T  cell  clone  PJB-20 
was derived from PL/J mice immunized with bovine MBP, a form of intact MBP 
that does not induce EAE in bomozygote PL/J mice. All three encephalitogenic 
T  cell clones recognize the N-terminal peptide of MBP (Table III) in association 
with I-A  u class II determinants  (Table  IV). 
Classic histologic features  of EAE are present,  including perivascular  infiltra- 
tion  in  the  white  matter  but not the gray matter  of the central  nervous system ZAMVIL ET AL.  2113 
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FIGURE 2.  Proliferative response ofa (PLSJ)FI MBP-specific  T cell line to mouse (self) MBP 
with PL/J (open circles), SjL/j (open triangles), and (PLSJ)Fj (closed circles) APC. 10  4 Fi T 
cells were cultured with 5 x  l0  s APC. Mouse MBP was added at the beginning of culture. 
The response of the Fl  T  cell line to rat MBP with SJL/J APC is shown (filled triangle). 
Proliferative responses were determined as described in Table I. 
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FIGURE 3.  Amino acid sequences of MBP from various species. 
(Fig.  5A).  These  infiltrates consist  of mononuclear cells (Fig.  5B).  Meningeal 
inflammation, demyelination, and a  variable degree of axonal degeneration has 
also been observed (Fig. 6A). Primary demyelination is found in areas ofcelhlar 
infiltration (Fig.  7A).  Remyelination by oligodendrocytes is also observed (Fig. 
7, B and C). T  cell clones that recognize the encephalitogenic N-terminal peptide 
of MBP, but not mouse (self) MBP, have neither produced clinical disease nor 
any of these histologic features, even when injected with 5  ×  10  6 cloned T  cells 
(Fig. 6B). 
The clinical course of representative individual (PLSJ)F1 mice following injec- 
tion of an encephalitogenic T  cell clone is shown in Fig. 8. The onset of paralysis 
is  dependent  upon  the  number  of cloned  T  cells  injected.  With  injection  of 
greater numbers of cells,  clinical  signs  appear earlier and  death is more likely 
(5).  Of  12  (PLSJ)F1  mice injected  with  5  ×  10  6  cloned T  cells,  all  developed 
acute EAE within  10-14 d, and died  1-16 d after the onset of paralysis. 
Chronic relapsing paralysis can occur after the injection of smaller numbers of 
encephalitogenic cloned T  cells (Fig. 8 A, B, D, and E). When injected with  10 5 
cells, not only is onset delayed, but the chronic relapsing paralysis is less severe 
(Fig. 8A). In addition to relapsing paralysis, one-third of mice injected with 5  × 2114  T  CELL  CLONES  MEDIATE  AUTOIMMUNE  PARALYSIS 
TABLE  III 
Specificity of Response of MBP-specific T Cell Clones to Peptide Fragments of MBP 
Pattern  Clone 
[~H]Tbymidine incorporation in response to MBP 
No  Rat MBP  Guinea pig  GP1-37  GP43-88  Bovine 
antigen  MBP  43-88 
1  Fi-5  469  7,624  6,783  10,569  542  668 
I  FI-11  143  777  904  1,079  164  ND 
I  F1-12  441  28,894  25,372  35,746  303  270 
I  FF21  162  11,090  2,899  15,881  341  91 
I  Fj-24  84  28,023  31,178  49,713  247  193 
ll  Fl-13  45  95,448  104  121  144  183 
Ill  Fi-2  244  78,430  77,155  ND  ND  ND 
Ill  F~-8  255  23,217  26,242  32,015  1.314  484 
III  Fl-14  286  7,434  8,102  ND  ND  ND 
Ill  F~-15  252  94,670  106,008  98,317  816  433 
III  FF16  238  74,286  83,687  95,650  213  230 
III  Fl-17  ND  ND  ND  ND  ND  ND 
III  F~-18  95  7,624  6,783  10,569  542  668 
III  FI-20  399  1,573  970  ND  ND  ND 
III  F~-22  ND  ND  ND  ND  ND  ND 
III  F1-27  295  143,795  129,501  ND  ND  ND 
IV  Fi-28  91  67,288  56,114  149  105  63 
I  PJR-25  213  108,007  83,489  108,853  577  388 
I  PJB-20  379  111,485  121,621  207,516  ND  ND 
All MBP peptides are products from pepsin cleavage of either intact guinea pig MBP or bovine MBP. 
These peptides have been isolated and purified as previously described (11,  12). All peptides were 
added initially to cultures to give a final concentration of 50 /~g/well. Intact proteins were added 
likewise, but at a concentration of 100 #g/ml. (PLSJ)FI APC were cultured with all (PLSJ)FI T  cell 
clones and PL/J APC were cultured with clones PJR-25 and PJB-20. Proliferation assay was done as 
described in Table I. ND, not determined. Positive proliferative responses are underscored. 
105  or  106  encephalitogenic  cloned  T  cells  developed  chronic  unremitting 
paraplegia, a  form not usually described (Fig. 8 C). 
A  subclone  of PJR-25,  derived  by  sorting  the  parent  clone  at  one  cell/well, 
also causes paralysis (5). Thus,  the encephalitogenic potential of this T  cell clone 
has not diminished by subcloning or continuous culture in vitro. 
Two  MBP-specific T  cell clones derived  from  two  other  independent  T  cell 
lines also cause  paralysis in (PLSJ)F1  mice.  Clone  FI-12, derived from  (PLSJ)F1 
mice immunized with rat MBP, causes chronic relapsing paralysis (5). T  cell clone 
PJB-20  was derived from homozygote  PL/J mice after immunization with intact 
bovine  MBP,  a  form  of MBP  that  does  not  induce  EAE  in  homozygote  PL/J 
mice. When  (PLSJ)F~  mice are injected with 5  x  106,  106,  or 5  x  102  PJB-20  T 
cells, all mice (12  of 12) have developed paralysis in the manner  described (Fig. 
8, B, D, and F). 
MBP-specific T  cell clones that respond to rat but not mouse  MBP,  were also 
tested  for  encephalitogenic  activity  by  injection  into  (PLSJ)F1  recipient  mice. ZAMV1L  ET  AL. 
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[SH]Thymidine incorporation in response to: 
Pattern  Clone 
Rat MBP plus: 
No  Rat MBP  Anti-  Anti-  Anti-  Anti- 
antigen  alone  1.A/3U.s  l_A/3U  i.EaU  I.E  u ×~ 
(10-2.16)  (40M)  (14-4-4)  (Y-17) 
I  Fr5  135  67,743  1,339  327  45,686  63,078 
I  Fl-11  ND  ND  ND  ND  ND  ND 
I  Frl2  125  48,328  8,828  2,474  47,324  47,461 
I  Fi-21  162  5,666  81  54  4,459  5,408 
I  Fr24  69  34,692  25,578  613  31,567  46,791 
I1  Fl-13  361  33,002  28,025  27,303  34,635  38,253 
III  Fi-2  244  78,430  197  201  60,125  80,410 
llI  FI-8  117  24,272  925  299  22,447  30,851 
III  F1-14  286  7,434  222  314  4,688  5,869 
Ill  Frl5  311  204,273  782  353  176,244  194,155 
III  Frl6  319  99,157  282  329  80,699  71,526 
Ill  Frl7  ND  ND  ND  ND  ND  ND 
Ill  Frl8  1,201  47,168  112  137  43,251  48,378 
Ill  Fr20  399  1,573  283  356  1,403  1,447 
Ill  Fr22  ND  ND  ND  ND  ND  ND 
111  Fr27  295  143,785  333  332  104,871  132,296 
IV  Fr28  224  52,438  33,721  46,757  146  29,009 
I  PJR-25 
I  PJB-20 
1,497  66,208  2,985  4,362  55,272  52,606 
379  111,475  749  4,481  77,629  ND 
All  mAb have been described previously, mAb  10-2.16  binds determinants Ia.17  on certain I-A/3 
chains, including I-A/3  u and I-Aft (15).  mAb 40M binds la.1, a determinant on I-A/3  u, but not I-Aft 
(16).  mAb 14-4-4  binds determinant Ia.7 expressed on Ea chains including Ea  u (17, 31).  mAb Y-17 
binds determinant Iam.44 on certain hybrid 1-E molecules, including EaUEff (18).  In these blocking 
studies, 1 gg of each mAb was added at the beginning of culture. Each clone was cultured with 5 X 
10 ~ (PLSJ)FI APC. (PLSJ)Fz  APC were cultured with all (PLSJ)F1 T  cell clones and PL/J APC were 
cultured with clones PJR-25 and PJB-20.  Proliferative responses were determined as described in 
Table  I.  ND,  not determined. For all  T  cell  clones tested, significant inhibition of proliferative 
responses to rat MBP by mAb are underscored. 
TABLE  V 
Patterns of Antigen Specificity and Ia Restriction of 17 (PLSJ)F1 
MBP-specific T Cell Clones 
Pattern  Class II restriction  Recognition of  Recognition of 
MBP 1-37  mouse MBP 
I  1-A (AaUAl3  u)  +  + 
I1  I-A (Aa~Aff)  -  - 
Ill  I-A (Aa~A~  ")  +  -- 
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FIGURE 4.  Proliferative response of an I-ALrestricted MBP-specific T cell clone to rat MBP 
with SJL/J  (open triangles); (B10 ×  SJL/J)F] (open diamond); (BALB/c X SJL/J)F] (open 
circle); (C3H/HeJ x  SJL/J)FI (open square); and (PLSJ)Ft (closed circle) APC. T cell clone 
SJ1.3 was derived  from SjL/J mice primed to bovine  MBP (21). 104 SJI.3 T  cells were 
cultured  with 100 #g/ml rat  MBP and  APC. Proliferative  responses were determined  as 
described in Materials and Methods. For each concentration of APC used, background (without 
rat  MBP) proliferations  and  proliferations  with rat  MBP  were  determined.  A cpm  was 
determined by subtracting  the  mean cpm of background  cultures  from the mean  cpm of 
cultures incubated with rat MBP at each respective concentration of APC. 
These  clones  were  administered  to  (PLSJ)F~  mice  in  the  same  manner  as  the 
encephalitogenic T  cell clones PJR-25, PJB-20, and Fl-12. Five individual clones, 
F1-8,  F]-I 3,  Fx-15,  F 1-16,  and  F]-I 8  were injected into (PLSJ)F]  recipient mice. 
Four of these T  cell clones, F~-8, F]- 15, F~- 16, and F~- 18, recognize a determinant 
within  the encephalitogenic N-terminal peptide of rat and guinea pig MBP  not 
shared  with  mouse  (self)  MBP  (Tables  II  and  III).  Clone  F1-13  recognizes  a 
determinant that is unique to rat MBP (Tables II and III). Even though injected 
with 5  ×  106 T  cells, no recipient mice developed clinical paralysis. 
None of the five control clones induce EAE despite a  strong in vitro prolifer- 
ative  response  to  MBP.  This  argues  against  passive  transfer  of  MBP  as  a 
mechanism  for  EAE  induction.  If any  trace  amount  of rat  MBP  is  passively 
transferred with PJR-25, PJB-20, or FI-12, one would expect similar amounts to 
have  been  transferred  with  the  control  clones  handled  in  the  same  manner. 
Furthermore,  viability of encephalitogenic  T  cell clones appears to be essential 
for induction of paralysis. None of six recipient (PLSJ)F1 mice developed paralysis 
after injection of 10 6 lethally x-irradiated (3,000 rads) PJR-25 T  cells. 
T  cell clones F]-21  and F]-24 have also been tested in vivo. These two clones 
show the same recognition pattern as PJR-25,  PJB-20, and Fl-12 (Tables I-IV). 
24 (PLSJ)F]  recipient mice have been injected with 5  ×  106 F]-21  or F]-24 cells 
each. None of these recipient mice have developed any signs of paralysis, even 5 
mo after injection. ZAMVIL  ET  AL.  2117 
FIGURE 5.  Histologic evidence of EAE induced by administration of clone PJR-25 (5 x  10  s 
cells). Perivascular infiltration is present in the white matter but not the gray matter of the 
CNS.  In this photomicrograph of a longitudinal section of spinal cord (A), three perivascular 
cuffs are indicated in the white matter (arrows). They are surrounded by more pale demyeli- 
hated areas. The gray matter, in the lower right hand corner, shows intact neurons (x  160). 
The cells in a  representative perivascular cuff (B) are lymphocytes and macrophages (x 700). 
Hematoxylin and eosin stains were used. 
Discussion 
Our experiments show that EAE can be induced with clonal populations of T 
cells. Depending on the number of cloned T  cells that are administered, different 
clinical forms of EAE are observed, including acute paralysis, chronic relapsing 
paralysis, and chronic unremitting paralysis. Histopathology reveals perivascular 
infiltration, demyelination, and remyelination. These observations establish EAE 
induced with T  cell clones as a pertinent model, with distinct features resembling 
MS.  Like  clinical  MS,  relapsing  and  chronic  unremitting  paralysis  are  seen. 
Demyelination, a  hallmark  of MS,  and  remyelination are  also  observed  with 
paralysis  induced by  MBP-specific T  cell clones.  In contrast,  antigen-induced 
EAE does not frequently cause demyelination (26).  Further, restriction of au- 
toimmune T  cell responses to certain Ia molecules can be demonstrated, provid- 
ing a  model for studying how human demyelinating diseases like MS might be 
linked to class II molecules of the major histocompatibility complex. 
These results confirm previous studies (2, 3) which have indicated that T  cells 
restricted by class II molecules of the major histocompatibility complex, bearing 
the L3T4 phenotype, play a central role in the induction of EAE. Previously, it 2118  T  CELL  CLONES  MEDIATE AUTOIMMUNE  PARALYSIS 
FIGURE 6.  Meningeal  inflammation,  demyelination,  and axonal degeneration are demon- 
strated (A) following chronic paralysis induced by clone PJR-25 (5 x  10~cells). These histologic 
features  were  not present  (B) following injection  of clone Fl-15  (5  X 106 cells). Toluidine 
blue-stained, Epon-embedded,  l-~m sections (x 700). 
FIGURE 7.  Primary demyelination,  characterized by an intact  axon that has lost its myelin 
sheath  (A), was  found  in  areas  of cellular  infiltration  by electron  microscopy  (x 35,000). 
Remyelination  by oligodendrocytes (B and  C) also  can  be found (X 30,000).  This  mouse 
showed chronic paralysis after receiving PJR-25 (5 x  105 cells). 
has been shown that the predominant  lineage of T  cells in EAE lesions is Ly-1 +, 
Lyt-2- (6), class II-restricted cells (7). It has been shown (27) that class II antigens 
appear  on  vascular  endothelium  within  the  CNS  early  in  the  development  of 
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FIGURE 8.  Clinical observation of individual (PLSJ)FI recipient mice following injection of 
T  cell clone PJR-25. Representative mice from each of the following groups are shown: A (10  b 
cells); B and C (5 x  105); D and E (106); F (5 ×  106). Clinical disease was graded as follows: 0, 
no observable signs of clinical disease; 1, loss of tail tone only; 2, mild paraparesis; 3, moderately 
severe paraparesis; 4, complete paraplegia; 5, moribund; -{, death. In vivo administration of 
encephalitogenic MBP specific T  cell clones is described in Materials and Methods. 
antigens in vitro, and are capable of presenting MBP to MBP-specific T  cell lines 
(18).  Thus,  T  cell clones may recognize  MBP in association with particular  Ia 
molecules present in brain and spinal cord, or on vascular endothelial cells within 
these organs. 
One prerequisite for MBP-specific T  cell clones to induce autoimmune paral- 
ysis is their ability to recognize mouse (self) MBP. These T  cell clones isolated 
from independently-derived MBP-specific T  cell  lines all recognize an epitope 
within the N-terminus of mouse (self) MBP, and are  100%  encephalitogenic at 
the cell  concentrations tested.  In  contrast,  two other clones,  Fi-21  and  F]-24, 
which have a  similar recognition pattern as encephalitogenic T  cell clones, do 
not cause paralysis, even when injected with as many as 5  X  106 T  cells. Thus, 
although recognition of mouse (self) MBP appears to be a prerequisite, it is not 2120  "F  CELL  CLONES  MEDIATE  AUTOIMMUNE  PARALYSIS 
a sufficient condition for these T  cell clones to cause paralysis in (PLSJ)F~  mice. 
It  is  possible  that  these  two  clones  may  respond  to  a  nonencephalitogenic 
determinant  within  the  N-terminus  which  is  distinct  from  that  recognized  by 
encephalitogenic  T  cell  clones.  This  possibility is  currently  being  tested  with 
synthetic  peptides  derived  from  the  aa  sequence  for  the  N-terminal  1-37  aa 
peptide of MBP. 
Other  properties  of encephalitogenic  T  cells,  in  addition  to recognizing  an 
encephalitogenic epitope of MBP, are probably important for induction of EAE. 
Clones that cause paralysis may have a greater capability to migrate to the CNS. 
When analyzed by fluorescence-activated cell sorter analysis, encephalitogenic T 
cell clone PJR-25 was negative for the expression of MEL-14 (data not shown), 
a cell surface marker that is associated with lymphocyte homing to high endothe- 
lial  venules (29). Further,  it is not known whether injected MBP-specific T  cells 
directly mediate the observed pathogenesis within the CNS. These T  cells may 
interact with other cell types, including macrophages,  B cells, and plasma cells, 
which have been observed in EAE lesions (7). Thus, the nonencephalitogenic  T 
cell clones may differ from encephalitogenic T  cells in their response to or release 
of certain lymphokines, a possibility that is currently being investigated. 
A clear bias in the pattern of responsiveness to self-MBP emerged in the T  cell 
lines, and the group oft  cell clones derived from the (PLSJ)F1 mice. The results 
revealed a deficiency of priming to MBP in the context of I-A  5 (Tables I-IV and 
Figs.  1 and 2) in (PLSJ)F1 mice. Further,  T  cells that do respond to rat MBP in 
association with  I-A  s do not recognize a  shared determinant  with mouse MBP. 
These results were evident when examining  the responses of individual  T  cell 
clones, and  were confirmed  when analyzing  the  MBP-primed T  cell line  from 
which these clones were derived.  In  contrast,  lymph node cells removed from 
SjL/j  mice primed  to rat  MBP proliferate  in  response  to either  rat  or mouse 
MBP (data not shown). Thus, it appears that (PLSJ)F1 and SjL/j mice may differ 
in the repertoire of I-A~-restricted MBP-specific T  cells. 
One possibility that  may have  influenced  the  relative  lack of I-A~-restricted 
MBP-specific T  cells in  (PLSJ)F1 mice is that  these T  cells may have been lost 
when  generating  a  continuous  T  cell  line.  This  possibility seems unlikely  for 
several reasons:  first,  the  T  cells were cloned at an  early stage,  namely at the 
time of the second stimulation  with  splenic APC.  These results were observed 
again with another independently generated (PLSJ)Fl  MBP-specific T  cell line. 
Furthermore,  Fritz et al. (22) observed a  lack of priming to MBP in association 
with H-2  s in primary cultures following immunization  of (PLSJ)Fl with MBP in 
adjuvant. 
It  is  interesting  that  MBP-specific  T  cell  clones  restricted  to  AaUAB  u and 
AaSAB  u class II molecules, which constitute a majority of the clones analyzed, all 
recognize the N-terminus. These results could reflect the possibility that a certain 
dominant  epitope(s)  exists  within  the N-terminus.  However, the  deficiency of 
proliferative response that occurs in association with I-A  s in (PLSJ)F1 mice is not 
specific for MBP. A deficient response has also been demonstrated (22) in primary 
cultures for antigens such as ovalbumin, purified protein derivative (PPD), and 
Listeria  monocytogenes, which  can  elicit  proliferative  responses  in  homozygous 
SJL/J mice. ZAMVIL  ET  AL.  2121 
A more plausible explanation for this bias in (PLSJ)F~ mice is that the level of 
expression of I-A  s is insufficient (at a certain  site) for effective antigen priming 
to proliferative T  cells. A different expression of I-A molecules has been reported 
(30) to occur in (C57B1/6 X A/J)F1 mice in which I-A  b expression is deficient. In 
another study, a relative lack of expression of certain combinatorial Ia molecules 
was observed in various hybrid F~  mice when one of the parents is B10.PL or 
PL/J, both  H-2  u, and  the other parent  is either  H-2  b,  H-2  k,  or H-2  s.  In  these 
studies,  it was shown (31,  32) that there is a  preferential  cis association of Ea  u 
with E/3  u to form  EaUE/3  u parental  heterodimers.  Differential  expression of I-E 
complexes has also been demonstrated in other Fa hybrids using cloned ailoreac- 
tive T  cells (33) and antigen-specific T  cell clones (34). 
It  is  intriguing  that  (PLSJ)F~  APC  can  express a  functional  level of I-A  s in 
vitro. I-AS-restricted MBP-specific T  cell clones proliferate in response to mouse, 
rat, and bovine MBP associated with (PLSJ)F~ spleen cells given as a  source of 
APC. This experiment has been repeated with other I-AS-restricted T  cell clones 
derived from SJL/J mice recognizing different epitopes on MBP.  In each case, 
(PLSJ)F~ APC can present MBP to these I-A~-restricted T  cell clones, as well as 
the  other  hybrid  F1  APC  (Fig.  4).  With  mAb  that  discriminate  between  I-A 
molecules of each parental  haplotype,  we are currently investigating  the possi- 
bility of a  differential  expression  of class  II  major  histocompatibility  complex 
molecules. 
A quantitative difference in expression of class II molecules has been found in 
EAE.  Although  strain  2  guinea pigs are resistant to EAE, strain  13 and hybrid 
strain  (2  x  13)F1  are  susceptible.  It  has  been  observed (35)  that  the  vascular 
endothelial  cells in strain  (2  x  13)F~ guinea pigs express quantitatively greater 
strain  13-specific  Ia  than  strain  2  Ia  antigens,  whereas normal  tissues do not 
show this difference. Thus, although it can be demonstrated in vitro that (PLSJ)F~ 
APC can express a functional level of I-A  s, in vivo there is clearly a bias against 
I-A  s restriction.  Identifying a  bias in antigen  responsiveness might be exploited 
in the treatment of autoimmune disease with anti-Ia antibodies directed against 
the  Ia  molecule associated with disease susceptibility (36).  It has been demon- 
strated (37) that in vivo treatment with anti-I-A antibodies is haplotype-specific. 
Thus,  it is possible to inhibit  the response to an antigen  under the control of a 
particular Ia molecule, while immune responses linked to other Ia molecules are 
left intact. 
The results from this study and others (31, 32, 38) demonstrate  the inability 
to predict immune responses based on major histocompatibility complex geno- 
type. A deficient response to MBP in association with H-2  s could not be predicted 
on the basis of the Ia genotype of the parental strains. This example emphasizes 
one of the difficulties in studying associations between diseases and HLA, relying 
solely on techniques for analysis of genomic DNA. It is intriguing that the analysis 
of these T  cell clones derived from (PLSJ)F1 mice demonstrated that I-A  u, not I- 
A s, is the restriction  element associated with responsiveness to the encephalito- 
genic N-terminus of mouse (self) MBP.  It is clear that  using antigen-specific T 
cell  clones  will  complement  studies  of genomic  DNA  in  the  analysis  of the 
functional role of Ia antigens in autoimmunity.  Such studies may help to clarify 2122  T  CELL CLONES MEDIATE AUTOIMMUNE PARALYSIS 
associations between HLA-D region genes and certain autoimmune diseases in 
humans. 
Summary 
Class II-restricted T  cell clones specific for myelin basic protein (MBP) have 
been  generated  from  PL/J  and  (PL/J  ×  SJL/J)F1  [((PLSJ)F d  mice  following 
sensitization to rat MBP.  Of 17 T  cell clones generated from (PLSJ)F1  mice, 5 
are I-A"(Ac~"A3  u) restricted, one is restricted to I-AS(Aa~A~S), 10 are restricted 
to hybrid I-A  t" × ~}F1 (AaSA~  ") determinants, and one clone is restricted to hybrid 
I_E(, × s> (EaUEfl~) molecules. Thus, of 16  I-A-restricted T  cell clones generated 
from (PLSJ)F1  mice, only one is  I-AS-restricted, reflecting a  lack of priming to 
MBP in association with I-AL T  cell clones restricted to I-A" and to I-E (Ea"E3  ~) 
molecules recognize mouse (serf) MBP. Furthermore, only the five T  cell clones 
restricted  to  I-A"  molecules recognize a  determinant in  common  with  mouse 
(self)  MBP  within  the  encephalitogenic N-terminal  peptide.  Three  such  I-A" 
restricted T  cell clones, derived independently, cause paralysis in 100% of (PL/J 
x  SJL/J)FI  mice  tested.  Acute,  chronic  unremitting,  and  chronic  relapsing 
paralysis are all  induced following injection of these clones.  Administration of 
greater numbers of cloned T  cells causes acute and fatal experimental allergic 
encephalomyelitis, while administration  of lower numbers  of cloned T  cells  is 
associated  with chronic  unremitting and  relapsing  paralysis.  Paralysis  induced 
with T  cell clones shares many clinical, immunologic, and histologic aspects with 
human demyelinating diseases such as multiple sclerosis. Histopathology reveals 
perivascular  lymphocytic infiltration, demyelination, and remyelination. These 
studies  demonstrate  the  utility of T  cell  clones  for  analyzing the  association 
between class II major histocompatibility complex molecules and disease suscep- 
tibility. 
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